核转录因子-&kappa;B在辛伐他汀抑制大鼠肺动脉平滑肌细胞增殖中的作用

刘忠强; 王晓琴; 刘瀚旻

doi:10.7499/j.issn.1008-8830.2015.02.016

PDF(1595 KB)

HTML

中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (2) : 185-189. DOI: 10.7499/j.issn.1008-8830.2015.02.016

论著·实验研究

核转录因子-κB在辛伐他汀抑制大鼠肺动脉平滑肌细胞增殖中的作用

刘忠强¹, 王晓琴², 刘瀚旻²

作者信息 +

Effect of NF-κB on proliferation of rat pulmonary artery smooth muscle cells inhibited by simvastatin

LIU Zhong-Qiang¹, WANG Xiao-Qin², LIU Han-Min²

Author information +

文章历史 +

摘要

目的探讨核转录因子-κB(NF-κB)在辛伐他汀抑制大鼠肺动脉平滑肌细胞(PASMC)增殖中的作用.方法随机将体外培养的大鼠PASMC分为对照组、血小板源性生长因子(PDGF)刺激组、辛伐他汀干预组和辛伐他汀联合小白菊内酯(NF-κB抑制剂)干预组,每组6个样本.通过MTT比色法和流式细胞术检测PASMC的增殖及细胞周期;通过免疫组织化学检测NF-κB蛋白的表达并进行图像分析;通过Real-Time PCR检测NF-κB mRNA的表达水平.结果 PDGF刺激组的各时间点MTT值,S期和G2+M期细胞比例,NF-κB蛋白及mRNA表达水平均较对照组显著升高(均P<0.05);给予辛伐他汀干预后,上述各指标水平均较PDGF刺激组降低(均P<0.05);辛伐他丁联合小白菊内酯干预后上述各指标下降更加明显,但与辛伐他汀干预组比较差异均无统计学意义(均P>0.05).结论辛伐他汀能抑制PASMC的增殖和细胞周期进程;NF-κB可能在辛伐他汀对PASMC增殖的抑制中起重要作用.

Abstract

Objective To explore the effects of NF-κB on proliferation of rat pulmonary artery smooth muscle cells (PASMC) inhibited by simvastatin. Methods PASMC isolated from rats and cultured in vitro were randomly divided into four groups (n=6 each): control, platelet-derived growth factor (PDGF) treatment, PDGF+simvastatin treatment, and PDGF+simvastatin+parthenolide (NF-κB inhibitor) treatment. MTT colorimetric assay and flow cytometry were performed to detect cell proliferation and cell cycle distribution. Immunohistochemistry was performed to detect the expression of NF-κB protein. Real-Time PCR was performed to detect NF-κB mRNA expression. Results Compared with the control group, MTT values of PASMC at all time points, cell proportion at the S phase and G2+M phase, NF-κB protein and mRNA expression increased significantly in the PDGF group (P<0.05). With the intervention of simvastatin, the levels of above indexes decreased compared with the PDGF group (P<0.05). With the intervention of simvastatin and parthenolide, the levels of above indexes decreased more obviously, but were not significantly different from those in the simvastatin intervention group. Conclusions Simvastatin can inhibit proliferation of PASMC and cell cycle process. NF-κB may play an important role in the inhibitory effect of simvastatin on the proliferation of PASMC.

导出引用

刘忠强, 王晓琴, 刘瀚旻. 核转录因子-κB在辛伐他汀抑制大鼠肺动脉平滑肌细胞增殖中的作用[J]. 中国当代儿科杂志. 2015, 17(2): 185-189 https://doi.org/10.7499/j.issn.1008-8830.2015.02.016

LIU Zhong-Qiang, WANG Xiao-Qin, LIU Han-Min. Effect of NF-κB on proliferation of rat pulmonary artery smooth muscle cells inhibited by simvastatin[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(2): 185-189 https://doi.org/10.7499/j.issn.1008-8830.2015.02.016

参考文献

[1] Tuder RM, Stacher E, Robinson J, et al. Pathology of pulmonary hypertension[J]. Clin Chest Med, 2013, 34(4): 639-650.
[2] Villegas LR, Kluck D, Field C, et al. Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome[J]. Antioxid Redox Signal, 2013, 18(14): 1753-1764.
[3] 刘瀚旻. 先天性心血管畸形的肺血管重构:一个历久弥新的话题[J]. 中国当代儿科杂志, 2013, 15(10): 805-809.
[4] Gao C, Xu W, Xiao W, et al. Simvastatin decreases stent-induced in-stent restenosis rate via downregulating the expression of PCNA and upregulating that of p27kip1[J]. J Interv Cardiol, 2013, 26(4): 384-391.
[5] Zhang Z, Zhang M, Li Y, et al. Simvastatin inhibits the additive activation of ERK1/2 and proliferation of rat vascular smooth muscle cells induced by combined mechanical stress and oxLDL through LOX-1 pathway[J]. Cell Signal, 2013, 25(1): 332-340.
[6] Shen RR, Zhou AY, Kim E, et al. TRAF2 is an NF-κB-activating oncogene in epithelial cancers[J]. Oncogene, 2015, 34(2): 209-216.
[7] Jeong IK, Oh da H, Park SJ, et al. Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells[J]. Exp Mol Med, 2011, 43(12): 684-692.
[8] 罗勤, 高正祥, 曹丽丽, 等. 脾酪氨酸激酶对大鼠肺血管平滑肌细胞增殖的作用[J]. 中国当代儿科杂志, 2010, 12(11): 886-890.
[9] 李峻岭, 姜盛花, 段颖欣, 等. 硫酸吲哚酚对大鼠主动脉平滑肌细胞钙化影响的实验研究[J]. 中华临床医师杂志(电子版), 2013, 7(18): 8335-8338.
[10] 纪晓玲, 郭晓玲. 左心疾病相关性肺动脉高压的诊治进展[J]. 心血管病防治知识(学术版), 2014, (2): 155-157.
[11] Zeng WJ, Xiong CM, Zhao L, et al. Atorvastatin in pulmonary arterial hypertension(APATH) study[J]. Eur Respir J, 2012, 40(1): 67-74.
[12] Zhao G, Yu YM, Kaneki M, et al. Simvastatin protects hepatocytes from apoptosis by suppressing the TNF-α/caspase-3 signaling pathway in mice with burn injury[J]. Ann Surg, 2013, 257(6): 1129-1136.
[13] Kou R, Shiroto T, Sartoretto JL, et al. Suppression of Gαs synthesis by simvastatin treatment of vascular endothelial cells[J]. J Biol Chem, 2012, 287(4): 2643-2651.
[14] DiDonato JA, Mercurio F, Karin M. NF-κB and the link between inflammation and cancer[J]. Immunol Rev, 2012, 246(1): 379-400.
[15] Yang C, Ling H, Zhang M, et al. Oxidative stress mediates chemical hypoxia-induced injury and inflammation by activating NF-κb-COX-2 pathway in HaCaT cells[J]. Mol Cells, 2011, 31(6): 531-538.
[16] Gong J, Xie J, Bedolla R, et al. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer[J]. Clin Cancer Res, 2014, 20(5): 1259-1273.
[17] Andreasen AS, Kelly M, Berg RMG, et al. Type 2 diabetes is associated with altered NF-κB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS[J]. PLoS One, 2011, 6(9): e23999.
[18] Baumann B, Salem HH, Boehm BO. Anti-inflammatory therapy in type 1 diabetes[J]. Curr Diab Rep, 2012, 12(5): 499-509.
[19] Fang D, Yang S, Quan W, et al. Atorvastatin suppresses Toll-like receptor 4 expression and NF-κB activation in rabbit atherosclerotic plaques[J]. Eur Rev Med Pharmacol Sci, 2014, 18(2): 242-246.